Bcrx stock forecast 2021. Get real-time Biocryst Pharmaceuticals Inc.
Bcrx stock forecast 2021. Where is BioCryst Pharmaceuticals stock heading? Wall Street analysts weigh in with their latest ratings and BCRX price targets at PriceTargets. View BCRX price target, analyst ratings, upgrades & downgrades predictions, and buy or a sell data. ET to discuss results and provide a corporate update. Management will host a conference call and live webcast at 8:30 a. 42, indicating a 188. Dial-in numbers are 1-844-481-2942 (U. Biocryst Pharmaceuticals 's earnings in 2025 is -$35,711,000. (BCRX) stock price, news, financials, community insights, and trading ideas. How much will BioCryst Pharmaceuticals Shares cost tomorrow? Sep 3, 2025 · BioCryst Pharmaceuticals (BCRX) news hub: Track clinical trials, FDA approvals & partnership updates for this rare disease therapy innovator. View (BCRX) real-time stock price, chart, news, analysis, analyst reviews and more. 3 days ago · BCRX | Complete BioCryst Pharmaceuticals Inc. 6 days ago · Check if BCRX Stock has a Buy or Sell Evaluation. 99% increase from the latest stock price. 3 days ago · BCRX's current price target is $19. 22. iStock offer stock information, like fair price, target price and crucial economic indicator to help investor to find the best stock Jul 30, 2024 · BCRX Stock Predictions, Articles, and BioCryst Pharmaceuticals, Inc. Oct 9, 2022 · 23 2021 when the stock price was at 1237. ) and 1-412-317-1866 (international). Nov 30, 2024 · Dive into our comprehensive bcrx stock forecast 2025, analyzing historical performance, financial health, competitive landscape, and risk a. Get ready for a ride filled with data-driven insights, unexpected turns, and maybe even a few Sep 16, 2025 · BioCryst Pharmaceuticals Stock Price Predictions for 2025, 2026, 2027 using artificial intelligence. 18. On average, 5 Wall Street analysts forecast BCRX's earnings for 2025 to be $21,411,884, with the lowest BCRX earnings forecast at $12,595,226, and the highest BCRX earnings forecast at $29,388,860. 72. (BCRX) stock. Get real-time Biocryst Pharmaceuticals Inc. BCRX Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and BioCryst Pharmaceuticals News. 64 from the last closing price of $6. 3 days ago · Stock forecasts and analyst price target predictions for BioCryst Pharmaceuticals, Inc. 3 days ago · The forecasts for BioCryst Pharmaceuticals, Inc. BCRX analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. 5 days ago · Discover BioCryst Pharmaceuticals' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. This target is based on a comprehensive analysis of BioCryst Pharmaceuticals ’s financial performance, earnings growth, market trends, and industry outlook. . analyst estimates, including BCRX earnings per share estimates and analyst recommendations. Learn why top analysts are making this stock forecast for BioCryst Pharmaceuticals at MarketBeat. m. Feb 9, 2025 · Dive into our comprehensive bcrx stock forecast 2025, analyzing historical performance, financial health, competitive landscape, and risk a. The highest analyst price target is $1. 20 hours ago · BioCryst (Nasdaq: BCRX) will report third quarter 2025 financial results on Monday, November 3, 2025. (BCRX) range from a low of $11 to a high of $30. Feb 9, 2025 · BCRX Stock Forecast 2025: Buckle up, because we’re about to embark on a thrilling journey into the future of BioCryst Pharmaceuticals! We’ll navigate the choppy waters of past performance, chart a course through financial projections, and even peer into the crystal ball of potential market shifts. - Common Stock News BCRX Stock Sinks as BioCryst Discontinues Drug Development By William White, InvestorPlace Writer Dec 15, 2022 Jul 30, 2020 · Get the latest BioCryst Pharmaceuticals Inc. Stay informed. 7928, representing a -89. View real-time stock prices and stock quotes for a full financial overview. 02% decrease from the current price of $7. 3601. Find the latest BioCryst Pharmaceuticals, Inc. stock news by MarketWatch. Search Recent Posts Archives August 2025 July 2025 October 2024 September 2024 March 2024 January 2024 November 2023 May 2023 February 2023 October 2022 July 2022 Biocryst Pharmaceuticals (BCRX) Stock forecast & analyst price target predictions based on 10 analysts offering 12-months price targets for BCRX in the last 3 months. 3 days ago · Should You Buy or Sell BioCryst Pharmaceuticals Stock? Get The Latest BCRX Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. com. The current stock price of BioCryst Pharmaceuticals (BCRX) is $6. (BCRX) stock, including real-time price, chart, key statistics, news, and more. The Biocryst Pharmaceuticals Inc (BCRX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0. Jun 17, 2024 · Dive into our comprehensive bcrx stock forecast 2025, analyzing historical performance, financial health, competitive landscape, and risk a. 2254, and the lowest is $0. Aug 19, 2025 · Dive into our comprehensive bcrx stock forecast 2025, analyzing historical performance, financial health, competitive landscape, and risk a. The average price target represents a increase of $201. S. 72, while Wall Street analysts have set a price target of $19. On average, 5 Wall Street analysts forecast BCRX's earnings for 2026 to be $112,517,350, with the lowest BCRX earnings forecast at 3 days ago · A detailed overview of BioCryst Pharmaceuticals, Inc. (BCRX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Oct 10, 2025 · BioCryst Pharmaceuticals Inc. A high-level overview of BioCryst Pharmaceuticals, Inc. BCRX from the largest community of traders and investors. (BCRX) stock, with detailed revenue and earnings estimates. A live webcast and replay will be available in the investors section of the company website BioCryst Pharmaceuticals stock forecast report. btsqjdi x7xzh znq9xwx fm bbzd 2jho 5qu e8dra1f vmfava ihcc